Enzyme vs Streamflow — how do they compare? Enzyme trades at Rp30,212 (market cap Rp134,13M, Rp104,56M 24h volume), while Streamflow trades at Rp173.29 (market cap Rp44,53M, Rp1,21M 24h volume). The key difference: Enzyme is far larger — about 3× Streamflow's market cap, and Streamflow's supply is capped (252,7M / 1B STREAM (26%)) while Enzyme's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold Enzyme for 28 Days and Streamflow for 26 Days on average.
| MLN | STREAM | |
|---|---|---|
Market Cap | Rp134,13M | Rp44,53M |
Volume (24h) | Rp104,56M | Rp1,21M |
Circulating Supply | 3,3M MLN | 252,7M / 1B STREAM (26%) |
Typical Hold Time | 28 Days | 26 Days |
Signals from Pluang's Aura AI — not financial advice
Enzyme (MLN) currently holds a market capitalization of Rp134.13 million with a circulating supply of 3.3 million tokens. The asset shows moderate market activity with a hold time of 28 days indicating average investor retention. Recent market data suggests stable trading patterns within the decentralized finance ecosystem, though specific price action requires current exchange verification.
Outlook remains cautiously neutral given limited recent protocol updates. Key opportunities include potential DeFi ecosystem growth integration, while risks center on typical crypto volatility and regulatory uncertainty. Investors should monitor on-chain activity and exchange liquidity for clearer directional signals.
Streamflow (STREAM) is currently trading at Rp173.067 with a bullish technical signal from moving averages, though oscillators are neutral. The token shows strong trend momentum with ADX readings above 40. Current price is near the pivot point of Rp175, with immediate support at Rp170 and resistance at Rp178. Market cap stands at Rp43.86 million with 26% of max supply in circulation. No major protocol updates or ecosystem news were identified in recent crypto coverage.
Overall outlook is cautiously optimistic given bullish technical indicators, but limited by low market cap and liquidity. Key opportunities include potential breakout above Rp178 resistance, while major risks involve high volatility due to thin trading volumes and absence of recent fundamental developments. Investors should monitor for increased network activity or exchange listings that could improve liquidity.
What Pluang investors did over the last 30 days
No sentiment data available yet.
Enzyme is an easy-to-use on-chain asset management system that enables access to digital assets and DeFi from one simple, unified app. It provides a front-to-back execution and order management system, which provides fully automated reporting, risk management, administration, governance and operations.
Read more on MLN →Streamflow provides secure, user-friendly, and robust token infrastructure to create and distribute tokens across their entire lifecycle—from launch to maturity. By solving incentive misalignment, Streamflow ensures sustainable token economies.
Read more on STREAM →